These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32302704)
1. Usefulness of positive T wave in lead aVR in predicting arrhythmic events and mortality in patients with hypertrophic cardiomyopathy. Ekizler FA; Cay S; Ozeke O; Tak BT; Kafes H; Ozcan Cetin EH; Ozcan F; Topaloglu S; Tufekcioglu O; Aras D Heart Rhythm; 2020 Aug; 17(8):1312-1319. PubMed ID: 32302704 [TBL] [Abstract][Full Text] [Related]
2. Importance of lead aVR on predicting adverse cardiac events in patients with noncompaction cardiomyopathy. Ekizler FA; Cay S; Ulvan N; Tekin Tak B; Cetin EHO; Kafes H; Ozeke O; Ozcan F; Topaloglu S; Tufekcioglu O; Aras D Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12719. PubMed ID: 31609051 [TBL] [Abstract][Full Text] [Related]
3. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy. Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421 [TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy. Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of positive T wave in lead aVR: A novel marker of adverse cardiac outcomes in peripartum cardiomyopathy. Ekizler FA; Cay S; Kafes H; Ozeke O; Ozcan F; Topaloglu S; Temizhan A; Aras D Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12631. PubMed ID: 30653267 [TBL] [Abstract][Full Text] [Related]
7. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy. Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377 [TBL] [Abstract][Full Text] [Related]
8. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595 [TBL] [Abstract][Full Text] [Related]
9. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience. Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy. Hen Y; Tsugu-Yagawa M; Iguchi N; Utanohara Y; Takada K; Machida H; Takara A; Teraoka K; Inoue K; Takamisawa I; Takayama M; Yoshikawa T Heart Vessels; 2018 Jan; 33(1):49-57. PubMed ID: 28766047 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants. Rowin EJ; Burrows A; Madias C; Estes NAM; Link MS; Maron MS; Maron BJ Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008123. PubMed ID: 32897759 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography. Ichida M; Nishimura Y; Kario K J Cardiol; 2014 Oct; 64(4):265-72. PubMed ID: 24674752 [TBL] [Abstract][Full Text] [Related]
14. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216 [TBL] [Abstract][Full Text] [Related]
15. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647 [TBL] [Abstract][Full Text] [Related]